Baycox Iron

RSS

toltrazuril / iron (III) ion

Authorised
This medicine is authorised for use in the European Union.

Overview

Baycox Iron is a veterinary medicine. It is used in young piglets on farms which have been affected in the past by the parasitic infection coccidiosis to prevent diarrhoea caused by a new coccidiosis infection. Coccidiosis is a disease of the gut which results in reduced growth due to diarrhoea.  Infected piglets shed disease spores (oocysts) in their faeces that can spread the infection. Baycox Iron is also used to reduce spread of the infection through passage of oocysts in faeces, and at the same time to prevent iron deficiency anaemia due to the limited iron reserves of new-born piglets, low iron content of milk and high growth rate of suckling piglets.

Baycox Iron contains the active substances toltrazuril and gleptoferron (an iron-containing compound).

This EPAR was last updated on 07/04/2020

Authorisation details

Product details
Name
Baycox Iron
Agency product number
EMEA/V/C/004794
Active substance
  • Iron(iii) ion
  • toltrazuril
International non-proprietary name (INN) or common name
  • toltrazuril
  • iron (III) ion
Species
Pigs (piglets)
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP51AJ51
Publication details
Marketing-authorisation holder
Bayer Animal Health GmbH
Date of issue of marketing authorisation valid throughout the European Union
20/05/2019
Contact address

D-51368 Leverkusen 
Germany

Product information

31/03/2020 Baycox Iron - EMEA/V/C/004794 - IG/1213

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

toltrazuril, combinations

Therapeutic indication

For the concurrent prevention of clinical signs of coccidiosis (such as diarrhoea) in neonatal piglets on farms with a confirmed history of coccidiosis caused by Cystoisospora suis, and prevention of iron deficiency anaemia.

Assessment history

How useful was this page?

Add your rating